Description: 

Methoxsalen (also known as 8-Methoxypsoralen, 8-MOP) is a compound that belongs to a group of medicines known as psoralens, which are photosensitizing agents used in conjunction with ultraviolet (UV) A light therapy to treat certain skin conditions. Its primary use is in the treatment of psoriasis, eczema, vitiligo, and some types of cutaneous lymphoma. Methoxsalen modifies the way skin cells receive the UVA light, helping to control the growth of abnormal skin cells.

Uses of Methoxsalen:

1. Psoriasis: Methoxsalen, combined with UVA light (a treatment known as PUVA), can help reduce the symptoms of severe psoriasis by slowing down the growth of skin cells.

2. Vitiligo: In vitiligo, where patches of skin lose their pigment, Methoxsalen can be used to increase the skin's sensitivity to UVA light, potentially restoring some color to the white patches.

3. Eczema: Methoxsalen may also be used in the treatment of severe eczema, in combination with UVA light therapy.

4. Cutaneous T-Cell Lymphoma: For certain stages of this type of skin lymphoma, Methoxsalen with UVA light therapy can be an effective treatment option.

Synonym: 8-Methoxypsoralen, XANTHOTOXIN, Meladinine, Oxypsoralen, 9-Methoxy-7H-furo[3,2-g]chromen-7-one, 8-MOP, Oxsoralen, Xanthotoxine, Ammoidin, Deltasoralen, Dermox, Geroxalen, Méladinine, Meladinina

Molecular Formula: C12H8O4

Molecular Weight: 216.19 g/mol

Appearance: Off-white crystalline solid

Purity: 98.0~102.0%

Melting Point: 143.0~148.0℃

Boiling Point: 276.6°C (rough estimate)

Storage Condition: Keep container tightly closed in a dry and well-ventilaed place.

Solubility: Practically insoluble in water

Shelf Life: >2 years if stored properly

HS Tariff Code: 2932209090